Hubei Guangji Pharmaceutical Co.,Ltd. Fundamental Rankings

This page is comprehensive fundamental data for Hubei Guangji Pharmaceutical Co.,Ltd.. Fundamentals are ordered by how Hubei Guangji Pharmaceutical Co.,Ltd. ranks compared to other companies (ordered high to low). All money values are in CNY. All data is powered by Quandl.

Cite in Wikipedia:

Indicator Value n/price Rank Date Historic
Long term accounts payable256,242,7780.08829322015-06-30historic
Construction materials4,195,1780.00145852015-06-30historic
Diluted eps-00.0912015-06-30historic
Estimated liabilities6,658,0830.002291242015-06-30historic
Cash paid for other financing activities43,686,2460.015051512015-06-30historic
Intangible assets179,837,1140.061971652015-06-30historic
Long term borrowings317,000,0000.109231872015-06-30historic
Purchases of fixed assets and others73,875,2560.025462112015-06-30historic
Other payables114,659,8830.039512322015-06-30historic
Net cashflow from financing activities146,236,3080.050392742015-06-30historic
Financial expenses18,067,5490.006232932015-06-30historic
Total non-current assets1,151,077,9980.396633312015-06-30historic
Other receivables32,461,3280.011193312015-06-30historic
Fixed assets532,419,8790.183463412015-06-30historic
Other current assets54,928,7320.018933462015-06-30historic
Payroll payable14,295,0000.004933572015-06-30historic
Refunds of taxes3,133,3100.001083572015-06-30historic
Accounts payable207,740,0070.071583662015-06-30historic
Total liabilities1,228,420,5060.423283722015-06-30historic
Long term equity investment28,826,9680.009933982015-06-30historic
Cash inflows from financing activities357,728,8380.123264042015-06-30historic
Net change in cash26,087,2470.008994392015-06-30historic
Investment income from associate and joint venture-454,305-1.6E-44982015-06-30historic
Net cash and cash equivalents ending balance208,268,9520.071765032015-06-30historic
Inventories197,888,7820.068195312015-06-30historic
Total liabilities and equity1,709,198,2600.588945432015-06-30historic
Short term borrowings117,511,6260.040496032015-06-30historic
Cash paid for dividends, profits or interests17,598,5300.006066572015-06-30historic
Disposal of fixed assets and others4,1820.07742015-06-30historic
Total cost of goods sold215,037,9890.07417952015-06-30historic
Non-operating loss117,2454.0E-58242015-06-30historic
Notes receivable2,351,0138.1E-48562015-06-30historic
Minority interest4,698,2970.001628562015-06-30historic
Selling expenses7,907,9920.002728702015-06-30historic
Prepayment11,943,3730.004128722015-06-30historic
Cash outflows from operating activities198,524,0900.068418972015-06-30historic
Revenue185,004,0310.063759192015-06-30historic
Net cash flows from investing activities-73,521,074-0.025339772015-06-30historic
Cash inflows from operating activities151,896,1030.0523410102015-06-30historic
Comprehensive income attributable to minority shareholders-2,583,315-8.9E-410242015-06-30historic
Cash paid for taxes10,546,1750.0036310262015-06-30historic
Minority interests gain-2,583,315-8.9E-410362015-06-30historic
Capital reserve67,695,3250.0233311512015-06-30historic
Operating profit-30,138,262-0.0103812762015-06-30historic
Total comprehensive income-24,669,853-0.008512782015-06-30historic
Net income-24,669,853-0.008512812015-06-30historic
Total profit-24,669,853-0.008512822015-06-30historic